Found: 23
Select item for more details and to access through your institution.
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 1, p. 67, doi. 10.1007/s10549-024-07271-4
- By:
- Publication type:
- Article
Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score<sup>®</sup> test.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 3, p. 611, doi. 10.1007/s10549-019-05346-1
- By:
- Publication type:
- Article
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
- Published in:
- Journal of Pathology, 2010, v. 220, n. 2, p. 263, doi. 10.1002/path.2648
- By:
- Publication type:
- Article
Fetal neurenteric cyst causing hydrops: case report and review of the literature.
- Published in:
- Prenatal Diagnosis, 1999, v. 19, n. 2, p. 118, doi. 10.1002/(SICI)1097-0223(199902)19:2<118::AID-PD478>3.0.CO;2-5
- By:
- Publication type:
- Article
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920973130
- By:
- Publication type:
- Article
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0090-6
- By:
- Publication type:
- Article
Author Correction: Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 69, doi. 10.1007/s10549-017-4550-8
- By:
- Publication type:
- Article
Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 108, n. 2, p. 233, doi. 10.1007/s10549-007-9590-z
- By:
- Publication type:
- Article
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The analytical validation of the Oncotype DX Recurrence Score assay.
- Published in:
- Ecancermedicalscience, 2016, v. 10, n. 674-708, p. 1, doi. 10.3332/ecancer.2016.675
- By:
- Publication type:
- Article
Molecular Predictors of 3D Morphogenesis by Breast Cancer Cell Lines in 3D Culture.
- Published in:
- PLoS Computational Biology, 2010, v. 6, n. 2, p. 1, doi. 10.1371/journal.pcbi.1000684
- By:
- Publication type:
- Article
Molecular characterization of breast cancer needle core biopsy specimens by the 21‐gene Breast Recurrence Score test.
- Published in:
- Journal of Surgical Oncology, 2020, v. 122, n. 4, p. 611, doi. 10.1002/jso.26050
- By:
- Publication type:
- Article
Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance.
- Published in:
- NPJ Precision Oncology, 2020, v. 4, n. 1, p. 1, doi. 10.1038/s41698-020-0118-x
- By:
- Publication type:
- Article
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 9, p. 912, doi. 10.3390/diagnostics14090912
- By:
- Publication type:
- Article
Genomic signatures of cancer: Basis for individualized risk assessment, selective staging and therapy.
- Published in:
- Journal of Surgical Oncology, 2011, v. 103, n. 6, p. 563, doi. 10.1002/jso.21838
- By:
- Publication type:
- Article
Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 10, p. 701, doi. 10.1093/jnci/djt067
- By:
- Publication type:
- Article